Qifeng Yang

38PUBLICATIONS
24CO-AUTHORS
Molecular targetsTumour immunologyPsychosocial aspects of childbirth and perinatal mental healthCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jun 19, 2026
Alternative splicing rewires breast cancer and opens therapeutic avenues.

|May 27, 2026
Targeting KDM3B Elicits Anti-tumor Immunity by Alleviating SHP1-mediated STING Suppression in Triple-Negative Breast Cancer.

|Dec 05, 2025
TRIM38 Suppresses Breast Cancer Progression via Modulating SQSTM1 Ubiquitination and Autophagic Flux.

Shan Jiang, Lijuan Wang, Dianwen Han

|Aug 28, 2025
Correction: COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.

Xi Chen, Chenao Ma, Yaming Li

|Jul 30, 2025
EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast Cancer.

Yajie Wang, Yiran Liang, Dan Luo

|Jul 24, 2025
The USP1-WDR48 deubiquitinase complex functions as a molecular switch regulating tumor-associated macrophage activation and anti-tumor response.

Dianwen Han, Lijuan Wang, Shan Jiang

Pageof 7

Frequent Collaborators

6 joint publications

Lijuan Wang

3 joint publications

Guohong Hu

3 joint publications

Peng Su

3 joint publications

Ning Zhang